03/28/08 - TyRx Pharma, Inc. Announces the Appointment of
Gary Young, PharmD, MBA as Vice President, Marketing

02/27/08 - TyRx Pharma, Inc. Raises $25 Million in Private Financing

01/17/08 - TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGISRX™ Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacemaker or Implantable Cardioverter Defibrillator (ICD) When Implanted in the Body

12/11/07 - TyRx Pharma, Inc., Announces the Appointment of Robert M. (Bob) Mattioli as Vice President, Commercial Development

10/24/07 - TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD

08/09/07 - TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President,
Clinical and Regulatory Affairs

03/19/07 - TyRx Pharma, Inc. Announces Presentation of the Results of an In-Vivo Efficacy Study Regarding PIVIT™ CRM at the Heart Rhythm Society Meeting

02/26/07 - TyRx Pharma, Inc., and JFC Technologies Signs Manufacturing Supply Agreement

01/29/07 - TyRx Pharma, Inc. Announces Strategic Alliance

10/16/06 - TyRx Pharma, Inc. Announces Submission of a Premarket Application for PIVIT™ CRM, an Innovative Mesh Pouch Designed To Hold and Reduce Bacterial Colonization of a Pacemaker or Implantable Defibrillator Pulse Generator (ICD) When Implanted In the Body

07/24/06 -TyRx Pharma, Inc., Announces FDA Clearance of PIVIT™ AB, a Novel Antimicrobial-
Coated Surgical Mesh

06/20/06 - TyRx Pharma, Inc., and Forrest T. Smith, PhD, Awarded the 2006 Fruchaud Prize for Best Scientific Poster Presentation during the 3rd International Hernia Congress

05/15/06 - TyRx Pharma, Inc., Announces the Election of Dr. Mason Diamond as Industry Representative to the FDA Advisory Committee on Dental Products

03/06 – TyRx Pharma Inc. Start-ups Across healthcare\

02/27/06 – Physicians Weekly/Bioresorbable Polymer Surgical Mesh

01/30/06 – TyRx Pharma, Inc., Announces the Signing of Exclusive License Agreement

01/23/06 – TyRx Says Combination Products Offer Greater Opportunity than Drug Delivery

01/17/06 – TyRx Announces FDA 510(K) Filling For New Antibiotic Eluting Surgical Mesh

01/09/06 – TyRx Pharma’s Anesthetic Coated Surgical Mesh Combination Product Assigned to “Device” Center at FDA

01/03/06 – TyRx Announces FDA 510(k) Clearance for New Surgical Mesh

11/7/05 – TyRx Pharma, Inc. Joins the Combination Products Coalition

10/17/05 – TyRx Pharma, Inc. Joins the Combination Products Coalition

05/09/05 – TyRx Pharma, Inc. Announces Two Senior Staff Additions

04/20/05 – TyRx Pharma, Inc. Announces Appointments to Its Board of Directors

02/05 – Interview with Bill Edelman

01/05 – TyRx Pharma, Inc. Announces Equity Investment
by Boston Scientific Corporation

1/7/05 – Closed $4.0M Series D Financing Round

9/22/04 – Restated License Agreement for core technology with Rutgers, The State University of New Jersey

9/15/04 – Relocated to Monmouth Junction 7,200ft2 Facility

8/12/04 – Closed $1.5M Interim Financing Round


 









Dec 2, 2008:
TYRX appoints David Elliot, Jr. Chief Operating Officer (pdf)

Nov 25, 2008:
TYRX, inc. announces 1,000th implant of AIGISRxTM anti-bacterial envelope (pdf)

Nov 17, 2008:
TYRX to sponsor webcast symposia featuring leading physicians discussing cardiac rhythm device related infection prevention (pdf)

Nov 10, 2008:
TYRX board appoints William G. Dempsey Independent Director (pdf)

Nov 2008:
Leading physicians to host medical device related infection prevention CME webcast (pdf)

Sep 26, 2008:
TYRX launches AIGISRx™ ICD to reduce surgical site infections associated with implantable cardioverter defibrillators (pdf)

May 14, 2008:
TyRx Pharma, Inc. Announces the First Human Implant of the AIGIS RX™ Anti-Bacterial Envelope in Cardiac Patient (pdf)

March 28, 2008:
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing (pdf)

February 27, 2008:
TyRx Pharma, Inc. Raises $25 Million in Private Financing (pdf)

January 17, 2008:
TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGISRX™ Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacemaker or Implantable Cardioverter Defibrillator (ICD) When Implanted in the Body (pdf)

December 11 , 2007:
TyRx Pharma, Inc., Announces the Appointment of Robert M. (Bob) Mattioli as Vice President, Commercial Development (pdf)

October 24, 2007:
TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD (pdf)
>>more info

August 9, 2007:
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs (pdf)
>>more info

March 19, 2007:
TyRx Pharma, Inc. Announces Presentation of the Results of an In-Vivo Efficacy Study Regarding PIVIT™ CRM at the Heart Rhythm Society Meeting (pdf)
>>more info

February 26, 2007:
TyRx Pharma, Inc., and JFC Technologies Signs Manufacturing Supply Agreement (pdf)
>>more info

January 29, 2007:
TyRx Pharma, Inc. Announces Strategic Alliance (pdf)
>>more info

October 16, 2006:
TyRx Pharma, Inc. Announces Submission of a Premarket Application for PIVIT™ CRM, an Innovative Mesh Pouch Designed To Hold and Reduce Bacterial Colonization of a Pacemaker or Implantable Defibrillator Pulse Generator (ICD) When Implanted In the Body (pdf)
>>more info

July 24, 2006:
TyRx Pharma, Inc., Announces FDA Clearance of PIVIT™ AB, a Novel Antimicrobial-
Coated Surgical Mesh
(pdf)
>>more info

June 20, 2006:
TyRx Pharma, Inc., and Forrest T. Smith, PhD, Awarded the 2006 Fruchaud Prize for Best Scientific Poster Presentation during the 3rd International Hernia Congress (pdf)
>>more info

May 15, 2006:
TyRx Pharma, Inc., Announces the Election of Dr. Mason Diamond as Industry Representative to the FDA Advisory Committee on Dental Products (pdf)
>>more info

March 2006:
TyRx Pharma Inc. - Start-ups Across healthcare (pdf)
>>more info

February 27, 2006:
Physicians Weekly/Bioresorbable Polymer Surgical Mesh (pdf)
>>more info

January 30, 2006:
TyRx Pharma, Inc., Announces the Signing of Exclusive License Agreement with Baylor College of Medicine and The University of Texas M. D. Anderson Cancer Center (pdf)
>>more info

January 23, 2006:
TyRx Says Combination Products Offer Greater Opportunity than Drug Delivery (pdf)
>>more info

January 17, 2006:
TyRx Announces FDA 510(K) Filling For New Antibiotic Eluting Surgical Mesh (pdf)
>>more info

January 09, 2006:
TyRx Pharma’s Anesthetic Coated Surgical Mesh Combination Product Assigned to “Device” Center at FDA (pdf)
>>more info

January 03, 2006:
TyRx Announces FDA 510(k) Clearance for New Surgical Mesh (pdf)
>>more info

November 07, 2005:
TyRx Pharma, Inc. Joins the Combination Products Coalition (pdf)
>>more info

October 17, 2005:
TyRx Announces FDA 510(k) Filing for New Surgical Mesh (pdf)
>>more info

May 09, 2005:
TyRx Pharma, Inc. Announces Two Senior Staff Additions (pdf)
>>more info

April 20, 2005:
TyRx Pharma, Inc. Announces Appointments to Its Board of Directors (pdf)
>>more info

February 2005:
Interview with Bill Edelman, CEO, on Wall Street Reporter. (mp3)
>>more info

January 2005:
TyRx Pharma, Inc. Announces Equity Investment
by Boston Scientific Corporation
(pdf)
>>more info


 TyRx Pharma, Inc. 1 Deer Park Drive, Suite G, Monmouth Junction, New Jersey 08852 | Voice: (732) 246-8676 | Fax: (732) 246-8677 | information@tyrxpharma.com
New York Web Design